Michael Rome

Director/Board Member at Remix Therapeutics, Inc.

39 year

Health Technology

Finance

Consumer Services

Profile

Michael Rome is currently the Director at Remix Therapeutics, Inc. and the Vice President at Foresite Life Sciences Corp.
He previously worked as the Director at Pharvaris NV from 2019 to 2020, Independent Director at Theseus Pharmaceuticals, Inc. from 2021 to 2024, Director & Vice President at FS Development Corp.
from 2020 to 2021, and Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024.
Dr. Rome has an undergraduate degree from the University of California, Los Angeles and a doctorate degree from the California Institute of Technology.

Michael Rome active positions

Companies	Position	Start
Foresite Life Sciences Corp. Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA.	Corporate Officer/Principal	01/01/2021
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Director/Board Member	-

All active positions of Michael Rome

Former positions of Michael Rome

Companies	Position	End
KINNATE BIOPHARMA INC.	Director/Board Member	03/04/2024
THESEUS PHARMACEUTICALS, INC.	Director/Board Member	14/02/2024
FS DEVELOPMENT CORP.	Director/Board Member	01/02/2021
PHARVARIS N.V.	Director/Board Member	31/12/2020
PARDES BIOSCIENCES, INC.	Director/Board Member	-

See the detail of Michael Rome's experience

Training of Michael Rome

University of California, Los Angeles	Undergraduate Degree
California Institute of Technology	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Rome's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PHARVARIS N.V.	Health Technology

Private companies	6
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA.	Health Technology
Kinnate Biopharma, Inc. Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.	Health Technology
FS Development Corp. FS Development Corp. Financial ConglomeratesFinance FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA.	Finance
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Health Technology
FS Development Corp. II FS Development Corp. II Financial ConglomeratesFinance FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA.	Finance
Foresite Life Sciences Corp. Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA.	Finance